الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> SARS-CoV>>Nelfinavir

Nelfinavir

رقم الكتالوجGC17709

Nelfinavir (AG-1341) هو مثبط إنزيم بروتياز HIV-1 قوي ومتوفر حيوياً عن طريق الفم (Ki = 2 نانومتر) لعدوى فيروس العوز المناعي البشري

Products are for research use only. Not for human use. We do not sell to patients.

Nelfinavir التركيب الكيميائي

Cas No.: 159989-64-7

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
124٫00
متوفر
2mg
54٫00
متوفر
5mg
99٫00
متوفر
10mg
149٫00
متوفر
50mg
342٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nelfinavir (AG-1341) is a potent and orally bioavailable HIV-1 protease inhibitor (Ki=2 nM) and antiviral agent for the treatment of HIV infection. Nelfinavir is a broad-spectrum, anticancer agent[1][2][3].

References:
[1]. Mondal D, et al. Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones. Ochsner J. 2013 Spring;13(1):76-90.
[2]. Gills JJ, et al. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that inducesendoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res. 2007 Sep 1;13(17):5183-94.
[3]. Kaldor SW, et al. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem. 1997 Nov 21;40(24):3979-85.

مراجعات

Review for Nelfinavir

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nelfinavir

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.